Transcripts BriaCell Therapeutics Corp. Nasdaq

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-20 EDT			5-day change	1st Jan Change
3.930 ^USD	-0.76%		+14.24%	-44.73%

08-05	BriaCell Gets FDA Approval to Start Phase 1/2a of Prostate Cancer Immunotherapy Study	MT
08-05	Briacell Therapeutics Corp Receives Fda Clearance to Initiate Bria-Pros+ Clinical Study in Prostate Cancer	CI

No results match your criteria